Aspire Biopharma Holdings (ASBP) Inventory Average (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Inventory Average came in at $329212.0 in Q2 2026, up 5.66% quarter-over-quarter from $311567.0 in Q1 2026.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Inventory Average (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Inventory Average for 2 consecutive years, with $329212.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 213.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | 329,212.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 329,212.00 |
| Mar 31, 2026 | 311,567.00 |
| Dec 31, 2025 | 144,298.50 |